Literature DB >> 5697050

Technique for lymphocyte transformation.

C R Pentycross.   

Abstract

Current techniques for lymphocyte transformation are evaluated and criticised. A simple technique, designed to meet these criticisms, is described in detail, with particular reference to lymphocyte separation and scoring methods.

Mesh:

Substances:

Year:  1968        PMID: 5697050      PMCID: PMC473724          DOI: 10.1136/jcp.21.2.175

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Separation of lymphocytes from peripheral blood by means of a glass wool column. A method for in vitro culture of lymphocytes.

Authors:  L BRANDT; J BORJESON; A NORDEN; I OLSSON
Journal:  Acta Med Scand       Date:  1962-10

2.  RADIORESISTANCE OF PHYTOHEMAGGLUTININ- TREATED NORMAL AND LEUKEMIC LYMPHOCYTES.

Authors:  R SCHREK; S STEFANI
Journal:  J Natl Cancer Inst       Date:  1964-02       Impact factor: 13.506

3.  SEPARATION OF VIABLE LYMPHOCYTES FROM HUMAN BLOOD.

Authors:  A S COULSON; D G CHALMERS
Journal:  Lancet       Date:  1964-02-29       Impact factor: 79.321

4.  SPECIFIC AND NON-SPECIFIC STIMULATION OF PERIPHERAL LYMPHOCYTES.

Authors:  N R LING; E M HUSBAND
Journal:  Lancet       Date:  1964-02-15       Impact factor: 79.321

5.  LYMPHOCYTE TRANSFORMATION AS AN IN-VITRO HISTOCOMPATIBILITY TEST.

Authors:  P C MOYNIHAN; J F JACKSON; J D HARDY
Journal:  Lancet       Date:  1965-02-27       Impact factor: 79.321

6.  The human small lymphocyte: its possible pluripotential quality.

Authors:  K CARSTAIRS
Journal:  Lancet       Date:  1962-04-21       Impact factor: 79.321

7.  The chromosome constitution of a human phenotypic intersex.

Authors:  D A HUNGERFORD; A J DONNELLY; P C NOWELL; S BECK
Journal:  Am J Hum Genet       Date:  1959-09       Impact factor: 11.025

8.  Differentiation of human leukemic leukocytes in tissue culture.

Authors:  P C NOWELL
Journal:  Exp Cell Res       Date:  1960-03       Impact factor: 3.905

9.  Simple methods for obtaining purified suspensions of lymphocytes.

Authors:  P Czerski; S Szmigielski; J Litwin
Journal:  Vox Sang       Date:  1966 Nov-Dec       Impact factor: 2.144

  9 in total
  10 in total

1.  A comparative study of nickel hypersensitivity by the lymphocyte transformation test in atopic and non-atopic dermatitis.

Authors:  C W Kim; E Schöpf
Journal:  Arch Dermatol Res       Date:  1976-11-26       Impact factor: 3.017

2.  Immune response in families of children with acute lymphoblastic leukaemia.

Authors:  D I Evans
Journal:  Arch Dis Child       Date:  1973-06       Impact factor: 3.791

3.  Lymphocyte transformation in young people.

Authors:  C R Pentycross
Journal:  Clin Exp Immunol       Date:  1969-07       Impact factor: 4.330

4.  Lymphocyte transformation in diseases of lymphoid tissue.

Authors:  C R Pentycross
Journal:  Proc R Soc Med       Date:  1970-04

5.  On the reactions of human synovial cells exposed to homologous leucocytes in vitro.

Authors:  J R Fraser; B J Clarris
Journal:  Clin Exp Immunol       Date:  1970-02       Impact factor: 4.330

6.  Tropical splenomegaly syndrome: long-term proguanil therapy correlated with spleen size, serum IgM, and lymphocyte transformation.

Authors:  A S Sagoe
Journal:  Br Med J       Date:  1970-08-15

7.  Lymphocyte transformation in patients with acute lymphoblastic leukaemia.

Authors:  L H Jones; R M Hardisty; D G Wells; H E Kay
Journal:  Br Med J       Date:  1971-11-06

8.  Cell mediated immunity at high altitude.

Authors:  I S Chohan; I Singh
Journal:  Int J Biometeorol       Date:  1979-03       Impact factor: 3.787

Review 9.  In vitro testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review.

Authors:  Abdelbaset A Elzagallaai; Sandra R Knowles; Michael J Rieder; John R Bend; Neil H Shear; Gideon Koren
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

10.  Lymphocyte transformation in immunoproliferative disorders.

Authors:  D Catovsky; P J Holt; D A Galton
Journal:  Br J Cancer       Date:  1972-06       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.